Skip to main content
SpringerLink
Log in

An Asthma Policy Model

  • Chapter
Operations Research and Health Care

Part of the book series: International Series in Operations Research & Management Science ((ISOR,volume 70))

Summary

Despite many proven advances in patient care over the last 10 years, asthma continues to impose a large and growing burden on society. Persistent clinician non-adherence to recommended practice is well documented, but little is known about the clinical impact and economic costs of alternative approaches to asthma patient care. In this chapter, we introduce the Asthma Policy Model, a state-transition simulation that we have developed to forecast asthma-related symptoms, acute exacerbations, quality-adjusted life expectancy, health care costs, and cost-effectiveness. We begin with a detailed survey of the epidemiological, clinical, and policy context that motivates our work. With a modeling audience in mind, we then describe the considerations that produced the current analytic structure and input datasets. We illustrate the policy relevance of the model by describing our recent work on the cost-effectiveness of inhaled corticosteroid therapy in a population of adult patients with mild-to-moderate disease. We close the chapter with a discussion of plans for future refinements and applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Asthma Education and Prevention Program (1997). Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2, Publication # 97-4051, U.S. Department of Health and Human Services, Washington, DC.

    Google Scholar 

  2. Mack, H., P. Johnson, H. Abbey, and R.C. Talcerno (1982). Prevalence of asthma and health service utilization of asthmatic children in a inner city. Journal of Allergy and Clinical Immunology, 70, 367–372.

    Google Scholar 

  3. Halfon, N. and P.W. Newacheck (1986). Trends in the hospitalization of acute childhood asthma, 1970–1984. American Journal of Public Health, 76, 1308–1311.

    Google Scholar 

  4. Evans, R. 3rd, D.E. Mullally, R.W. Wilson, P.J. Gergen, H.M. Rosenberg, J.S. Grauman, F.M. Chevarley, and M. Feinleib (1987). National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization, and death from asthma over two decades: 1965–1984. Chest, 91, 65S–74S.

    PubMed  Google Scholar 

  5. Sly, R.M. (1988). Mortality from asthma, 1979–1984. Journal of Allergy and Clinical Immunology, 82, 705–717.

    Google Scholar 

  6. Weiss, K.B., P.J. Gergen, and E.F. Crain (1992). Inner-city asthma. The epidemiology of an emerging US public health concern. Chest, 101, 362S–367S.

    PubMed  CAS  Google Scholar 

  7. National Heart, Lung, and Blood Institute (2000). Morbidity and Mortality: 2000 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Institutes of Health, Bethesda, MD.

    Google Scholar 

  8. Marder, D., P. Targonski, P. Orris, V. Persky, and W. Addington (1992). Effect of racial and socioeconomic factors on asthma mortality in Chicago. Chest, 101, 4265S–4429S.

    Google Scholar 

  9. Carr, W., L. Zeitel, and K.B. Weiss (1992). Asthma hospitalization and mortality in New York City. American Journal of Public Health, 82, 59–65.

    PubMed  CAS  Google Scholar 

  10. Martinez, F.D., A.L. Wright, L.M. Taussig, C.J. Holberg, M. Halonen, and W.J. Morgan (1995). Asthma and wheezing in the first six years of life. The Group Health Medical Associates. New England Journal of Medicine, 332, 133–138.

    Article  PubMed  CAS  Google Scholar 

  11. Kattan, M., H. Mitchell, P. Eggleston, P. Gergen, E. Crain, S. Redline, K. Weiss, R. Evans 3rd, R. Kaslow, C. Kercsmar, F. Leickly, F. Malveaux, and H.J. Wedner (1997). Characteristics of inner-city children with asthma: The National Cooperative Inner-City Asthma Study. Pediatric Pulmonology, 24, 253–262.

    Article  PubMed  CAS  Google Scholar 

  12. Kitch, B.T., G. Chew, H.A. Burge, M.L. Muilenberg, S.T. Weiss, T.A. Platts-Mills, G. O’Connor and D.R. Gold (2000). Socioeconomic predictors of high allergen levels in homes in the greater Boston area. Environmental Health Perspectives, 108, 301–307.

    PubMed  CAS  Google Scholar 

  13. Evans, R. (1992). Asthma among minority children. A growing problem. Chest, 101(Suppl), 368S–371S.

    PubMed  Google Scholar 

  14. Gottlieb, D.J., A.S. Beiser, and G.T. O’Connor (1995). Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest, 108, 28–35.

    PubMed  CAS  Google Scholar 

  15. Weiss, K.B., E.N. Grant, and T. Li (1999). The effects of asthma experience and social demographic characteristics on responses to the Chicago Community Asthma Survey-32. Chicago Asthma Surveillance Initiative Project Team. Chest, 116(Suppl 1), 183S–189S.

    PubMed  CAS  Google Scholar 

  16. Stableforth, D.E. (1987). Asthma mortality and physician competence. Journal of Allergy and Clinical Immunology, 80, 463–466.

    Article  PubMed  CAS  Google Scholar 

  17. Kravis, L.P. (1987). An analysis of fifteen childhood asthma fatalities. Journal of Allergy and Clinical Immunology, 80, 467–472.

    Article  PubMed  CAS  Google Scholar 

  18. Strunk, R.C., D.A. Mrazek, G.S.W. Fuhrmann, and J.F. LaBrecque (1985). Deaths from asthma in childhood. Can they be predicted? Journal of the American Medical Association, 254, 1193.

    Article  PubMed  CAS  Google Scholar 

  19. Barnes, P.J. (1989). A new approach to the treatment of asthma. Department of Thoracic Medicine, Brompton Hospital, London, United Kingdom. New England Journal of Medicine, 321, 1517–1527.

    PubMed  CAS  Google Scholar 

  20. Barnes, P.J. and I. Adcock (1993). Anti-inflammatory actions of steroids: molecular mechanisms. Trends in Pharmacological Sciences, 14, 436–441

    Article  PubMed  CAS  Google Scholar 

  21. Pearlman, D.S., P. Chervinsky, C. LaForce, J.M. Seltzer, D.L. Southern, J.P. Kemp, RJ. Dockhorn, J. Grossman, R.F. Liddle, and S.W. Yancey (1992). A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. New England Journal of Medicine, 327, 1420–1425.

    PubMed  CAS  Google Scholar 

  22. Henderson, W.R., Jr. (1994). Role of leukotrienes in asthma. Annals of Allergy, 72, 272–278.

    PubMed  Google Scholar 

  23. Buchner, D.A., L.T. Butt, A. De Stefano, B. Edgren, A. Suarez, and R.M. Evans (1998). Effects of an asthma management program of the asthmatic member: Patient centered results of a 2 year study in a managed care organization. American Journal of Managed Care, 4, 1288–1297.

    PubMed  CAS  Google Scholar 

  24. Hammarquist, C., M.L. Burr, and P.C. Gotzsche for the Cochrane Airways Group (2001). House dust mite control measures for asthma. Cochrane Database of Systematic Reviews, Issue 1.

    Google Scholar 

  25. Peat, J.K. and J. Li (1999). Reversing the trend: Reducing the prevalence of asthma. Journal of Allergy and Clinical Immunology, 130, 1–10.

    Google Scholar 

  26. Custovic, A., S.C.O. Taggart, H.C. Francis, M.D. Chapman, and A. Woodcock (1995). Exposure to house dust mite allergens and the clinical activity of asthma. Journal of Allergy and Clinical Immunology, 98, 64–72.

    Google Scholar 

  27. Durham, S.R. (1996). Allergen avoidance measures. British Thoracic Society. Respiratory Medicine, 90, 441–5.

    Article  PubMed  CAS  Google Scholar 

  28. Watson, W.T.A., A.B. Becker, and F.E.R. Simons (1993). Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. Journal of Allergy and Clinical Immunology, 91, 97–101.

    Article  PubMed  CAS  Google Scholar 

  29. Pedersen, B., R. Dahl, N. Lindqvist, and N. Mygind (1990). Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy, 45, 451–456.

    PubMed  CAS  Google Scholar 

  30. Grant, J.A., C.F. Nicodemus, S.R. Findlay, MM. Glovsky, J. Grossman, H. Kaiser, E.O. Meltzer, D.Q. Mitchell, D. Pearlman, and J. Selner (1995). Clinical aspects of allergic disease. Cetrizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology, 95, 923–932.

    Article  PubMed  CAS  Google Scholar 

  31. Corren, J., A. Harris, D. Aaronson, W. Beaucher, R. Berkowitz, E. Bronsky, R. Chen, P. Chervinsky, R. Cohen, J. Fourre, J. Grossman, E. Meltzer, A. Pedinoff, W. Strieker, and A. Wanderer (1997). Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. Journal of Allergy and Clinical Immunology, 100, 781–788.

    Article  PubMed  CAS  Google Scholar 

  32. Parmley, W.W. (1994). Clinical practice guidelines: does the cookbook have enough recipes? Journal of the American Medical Association, 272, 1374–1375.

    Article  PubMed  CAS  Google Scholar 

  33. Ellrodt, A.G., L. Conner, M. Riedinger, and S. Weingarten (1995). Measuring and improving physician compliance with clinical practice guidelines: a controlled interventional trial. Annals of Internal Medicine, 122, 277–282.

    PubMed  CAS  Google Scholar 

  34. Grimshaw, K., N. Freemantle, S. Wallace, I. Russell, B. Herwitz, I. Watt, A. Long, and T. Sheldon (1995). Developing and implementing clinical practice guidelines. Quality in Health Care, 4, 55–64.

    PubMed  CAS  Google Scholar 

  35. Adams, R.J., A. Fuhlbrigge, T. Guilbert, P. Lozano, and F. Martinez (2002). Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. Journal of Allergy and Clinical Immunology, 110, 58–64.

    Article  PubMed  Google Scholar 

  36. Windsor, R.A., W.C. Bailey, J.M. Richards Jr., B. Manzella, S.J. Soong, and M. Brooks (1990). Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma. American Journal of Public Health, 80, 1519.

    PubMed  CAS  Google Scholar 

  37. Gallefoss, F. and P.S. Bakke (2001). Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. European Respiratory Journal, 17, 206–213.

    Article  PubMed  CAS  Google Scholar 

  38. Wilson Pessano, S.R., P. Scamagas, G.M. Arsham, L. Chardon, S. Coss, D.F. German, and G.W. Hughes (1987). An evaluation of approaches to asthma self-management education for adults: the AIR/Kaiser Permanente study. Journal of Health Education, 14, 333–343.

    CAS  Google Scholar 

  39. Clark, N.M., C.H. Feldman, D. Evans, M.J. Levison, Y. Wasilewski, and R.B. Mellins (1986). The impact of health education on frequency and cost of health care use by low income children with asthma. Journal of Allergy and Clinical Immunology, 78, 108–115.

    Article  PubMed  CAS  Google Scholar 

  40. Lewis, C.E., G. Rachelefsky, M.A. Lewis, A de la Sota, and M. Kaplan (1984). A randomized trial of A.C.T. (asthma care training) for kids. Pediatrics, 74, 478–486.

    PubMed  CAS  Google Scholar 

  41. Tierce, J.C., W. Meller, B. Berlow, and W.C. Gerth (1989). Assessing the cost of albuterol inhalers in the Michigan and California Medicaid programs: a total cost-of-care approach. Clinical Therapeutics, 11, 53.

    PubMed  CAS  Google Scholar 

  42. Campbell, L.M., R.J. Simpson, M.L. Turbitt, and P.D.I. Richardson (1993). A comparison of the cost-effectiveness of budesonide 400 mg/day and 800 mg/day in the management of mild-to-moderate asthma in general practice. British Journal of Medical Economics, 6, 67–74.

    Google Scholar 

  43. Ross, R.N., M. Morris, S.R. Sakowitz, and B.A. Berman (1988). Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record based study. Clinical Therapeutics, 10, 188–203.

    PubMed  CAS  Google Scholar 

  44. Rutten-van-Molken, M.P.M.H., E.K.A. Van Doorslaer, M.C.C. Jansen, H.A.M. Kerstjens, and F.F.H. Rutten (1995). Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 151, 975–982.

    PubMed  CAS  Google Scholar 

  45. Connett, G.J., W. Lenney, and S.M. McConchie (1993). The cost-effectiveness of budesonide in severe asthmatics aged one to three years. British Journal of Medical Economics, 6, 127–270.

    Google Scholar 

  46. Gold, M.R., J.E. Siegel, L.B. Russel, and M.C. Weinstein, Eds. (1996). Report of the Panel on Cost-effectiveness in Health and Medicine. Cost-Effectiveness in Health and Medicine. Oxford University Press, New York.

    Google Scholar 

  47. Kuntz, K.M., B.T. Kitch, A.L. Fuhlbrigge, A.D. Paltiel, P.J. Neumann, and S.T. Weiss (2002). A novel approach to defining the relationship between lung function and symptom status in asthma. Journal of Clinical Epidemiology, 55, 11–18.

    Article  PubMed  Google Scholar 

  48. Fuhlbrigge, A.L., B.T. Kitch, A.D. Paltiel, K.M. Kuntz, P.J. Neumann, D.W. Dockery, and S.T. Weiss (2001). FEV1 is associated with risk of asthma attacks in a pediatric population. Journal of Allergy and Clinical Immunology, 107, 61–67.

    Article  PubMed  CAS  Google Scholar 

  49. Neumann, P.J., K. Blumenschein, A. Zillich, M. Johannesson, K.M. Kuntz, R.H. Chapman, S.T. Weiss, B.T. Kitch, A.L. Fuhlbrigge, and A.D. Paltiel (2000). Relationship between FEV1% predicted and utilities in adult asthma [Abstract]. Medical Decision Making, 20, 488.

    Google Scholar 

  50. Paltiel, A.D., A.L. Fuhlbrigge, B.T. Kitch, B. Liljas, S.T. Weiss, P.J. Neumann, and K.M. Kuntz (2001). Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model. Journal of Allergy and Clinical Immunology, 108, 39–46.

    Article  PubMed  CAS  Google Scholar 

  51. Sullivan, S.D., A. Elixhauser, A.S. Buist, B.R. Luce, J. Eisenberg, and K.B. Weiss (1996). National Asthma Education and Prevention Program working group report on the cost-effectiveness of asthma care. American Journal of Respiratory and Critical Care Medicine, 154, S84–S95.

    PubMed  CAS  Google Scholar 

  52. United States Bureau of the Census (1998). Statistical Abstract of the United States: 1998. Washington, DC.

    Google Scholar 

  53. Beck, J.R. and S.G. Pauker (1983). The Markov process in medical prognosis. Medical Decision Making, 3, 419–458.

    PubMed  CAS  Google Scholar 

  54. Sonnenberg, F.A. and J.R. Beck (1993). Markov models in medical decision making: a practical guide. Medical Decision Making, 13, 322–338.

    PubMed  CAS  Google Scholar 

  55. Crane, J., N. Pearce, C. Burgess, K. Woodman, B. Robson, and R. Beasley (1992). Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. International Journal of Epidemiology, 21, 737–744.

    PubMed  CAS  Google Scholar 

  56. Ortega, A.N., K.D. Belanger, M.B. Bracken, and B.P. Leaderer (2001). A childhood asthma severity scale: symptoms, medications, and health care visits. Annals of Allergy, Asthma, and Immunology, 86, 405–413.

    PubMed  CAS  Google Scholar 

  57. National Asthma Education and Prevention Program (1991). Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report. U.S. Department of Health and Human Services, Washington, DC, Publication # 91-3042.

    Google Scholar 

  58. Enright, P.L., M.D. Lebowitz, and D.W. Cockroft (1994). Physiologic measures: pulmonary function tests. Asthma outcomes. American Journal of Respiratory and Critical Care Medicine, 149, S9–S20.

    PubMed  CAS  Google Scholar 

  59. Enright, P.L., L.R. Johnson, J.E. Connett, H. Voelker, and A.S. Buist (1991). Spirometry in the Lung Health Study. Methods and quality control. American Review of Respiratory Disease, 143, 1215–1221.

    PubMed  CAS  Google Scholar 

  60. Kitch, B.T., A.L. Fuhlbrigge, K.M. Kuntz, P.J. Neumann, A.D. Paltiel, B. Rijeken, B. Schouten, D.S. Postma, and S.T. Weiss (1999). Relationship between FEV1 and subsequent asthma attacks. American Journal of Respiratory and Critical Care Medicine, 159, A135.

    Google Scholar 

  61. Thomas, P., R.N. Ross, and J.R. Farrar (1996). A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma. Clinical Therapeutics, 18, 939–952.

    Article  PubMed  CAS  Google Scholar 

  62. Donahue, J.G., S.T. Weiss, J.M. Livingston, M.A. Goetsch, D.K. Greineder, and R. Platt (1997). Inhaled steroids and the risk of hospitalization for asthma. Journal of the American Medical Association, 277, 887–891.

    Article  PubMed  CAS  Google Scholar 

  63. Finkelstein, J.A., M.B. Barton, J.G. Donahue, P. Algatt-Bergstrom, L.E. Markson, and R. Platt (2000). Comparing asthma care for Medicaid and non-Medicaid children in an HMO. Archives of Pediatrics and Adolescent Medicine, 154, 563–568.

    PubMed  CAS  Google Scholar 

  64. Rutten-van-Molken, M.P.M.H., E.K.A. Van Doorslaer, M.C.C. Jansen, H.A.M. Kerstjens, and F.F.H. Rutten (1995). Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 151, 975–982.

    PubMed  CAS  Google Scholar 

  65. Revicki, D.A., N.K. Leidy, F. Brennan-Diemer, S. Sorensen, and A. Togias (1998). Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest, 114, 998–1007.

    PubMed  CAS  Google Scholar 

  66. Neumann, P.J., K. Blumenschein, A. Zillich, M. Johannesson, K.M. Kuntz, R.H. Chapman, S.T. Weiss, B.T. Kitch, A.L. Fuhlbrigge, and A.D. Paltiel (2000). Relationship between FEV1% predicted and utilities in adult asthma. Medical Decision Making, 20, 488.

    Google Scholar 

  67. Pearlman, D.S., W. Stricker, S. Weinstein, G. Gross, P. Chervisnsky, A. Woodring, B. Prillaman, and T. Shah (1999). Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Annals of Allergy, Asthma, and Immunology, 82, 257–265.

    PubMed  CAS  Google Scholar 

  68. Noonan, M., P. Chervinsky, W.W. Busse, S.C. Weisberg, J. Pinna, B.P. de Boisblanc, H. Boltansky, D. Pearlman, L. Rephser, D. Kellerman (1995). Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. American Journal of Respiratory and Critical Care Medicine, 152, 1467–1473.

    PubMed  CAS  Google Scholar 

  69. Bel, E.H., M.C. Timmers, J. Hermans, J.H. Dijkman, and P.J. Sterk (1990). The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. American Review of Respiratory Disease, 141, 21–28.

    PubMed  CAS  Google Scholar 

  70. Fahy, J.V. and H.A. Boushey (1998). Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. European Respiratory Journal, 11(6), 1240–1247.

    Article  PubMed  CAS  Google Scholar 

  71. Galant, S.P., M. Lawrence, E.O. Meltzer, M. Tomasko, K.A. Baker, and D.J. Kellerman (1996). Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Annals of Allergy, Asthma, and Immunology, 77, 112–118.

    PubMed  CAS  Google Scholar 

  72. Kemp, J., A.A. Wanderer, J. Ramsdell, D.L. Southern, S. Weiss, D. Aaronson, and J. Grossman (1999). Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma. Annals of Allergy, Asthma, and Immunology, 82, 463–471.

    PubMed  CAS  Google Scholar 

  73. Li, J.T., L.B. Ford, P. Chervinsky, S.C. Weisberg, D.J. Kellerman, K.G. Faulkner, N.E. Herje, A. Hamedani, S.M. Harding, and T. Shah (1999). Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. Journal of Allergy and Clinical Immunology, 103, 1062–1068.

    PubMed  CAS  Google Scholar 

  74. McFadden, E.R., T.B. Casale, T.B. Edwards, J.P. Kemp, W.J. Metzger, H.S. Nelson, W.W. Storms, and M.J. Neidl (1999). Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. Journal of Allergy and Clinical Immunology, 104, 46–52.

    Article  PubMed  CAS  Google Scholar 

  75. Meltzer, E.O., H.A. Orgel, E.F. Ellis, H.N. Eigen, and M.P. Hemstreet (1992). Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. Journal of Allergy and Clinical Immunology, 90, 2–11.

    PubMed  CAS  Google Scholar 

  76. Nathan, R.A., J.L. Pinnas, H.J. Schwartz, J. Grossman, S.W. Yancey, A.H. Emmett, and K.A. Rickard (1999). A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma. Annals of Allergy, Asthma, and Immunology, 82, 521–529.

    PubMed  CAS  Google Scholar 

  77. Osterman, K., M. Carlholm, J. Ekelund, J. Kiviloog, K. Nikander, L. Nilholm, P. Salomonsson, V. Strand, P. Venge, and O. Zetterstrom (1997). Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. European Respiratory Journal, 10, 2210–2215.

    Article  PubMed  CAS  Google Scholar 

  78. Peden, D.B., W.E. Berger, M.J. Noonan, M.J. Noonan, M.R. Thomas, V.L. Hendricks, A.G. Hamedani, P. Mahajan, and K.W. House (1998). Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy and Clinical Immunology, 102, 32–38.

    Article  PubMed  CAS  Google Scholar 

  79. Reed, C.E., K.P. Offord, H.S. Nelson, J.T. Li, and D.G. Tinkelman (1998). Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. Journal of Allergy and Clinical Immunology, 101, 14–23.

    Article  PubMed  CAS  Google Scholar 

  80. Sheffer, A.L., C. LaForce, P. Chervinsky, D. Pearlman, and A. Schaberg (1996). Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. Family Practice, 42, 369–375.

    CAS  Google Scholar 

  81. Simons, F.E. (1997). A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. New England Journal of Medicine, 337, 1659–1665.

    Article  PubMed  CAS  Google Scholar 

  82. Tinkelman, D.G., C.E. Reed, H.S. Nelson, and K.P. Offord (1993). Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics, 92, 64–77.

    PubMed  CAS  Google Scholar 

  83. Evans, R. 3rd, D.I. Mullally, R.W. Wilson, P. J. Gergen, H.M. Rosenberg, J.S. Grauman, F.M. Chevarley, and M. Feinleib (1987). National Trends in Morbidity and Mortality of Asthma in the US. Chest, 91, 65S–73S.

    PubMed  Google Scholar 

  84. U.S. Bureau of the Census (1997). Statistical Abstract of the United States: 1997. Washington, DC.

    Google Scholar 

  85. Serra-Batlles, J., V. Plaza, E. Morejon, A. Comella, and J. Brugues (1998). Costs of asthma according to the degree of severity. European Respiratory Journal, 12, 1322–1326.

    Article  PubMed  CAS  Google Scholar 

  86. Stanford, R., T. McLaughlin, and L.J. Okamoto (1999). The cost of asthma in the emergency department and hospital. American Journal of Respiratory and Critical Care Medicine, 160, 211–215.

    PubMed  CAS  Google Scholar 

  87. Lewis, C.E., G. Rachelefsky, M.A. Lewis, A. de la Sota, and M. Kaplan (1984). A randomized trial of A.C.T. (asthma care training) for kids. Pediatrics, 74, 478–486.

    PubMed  CAS  Google Scholar 

  88. Ross, R.N., M. Morris, S.R. Sakowitz, and B.A. Berman (1988). Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study. Clinical Therapeutics, 10, 188–203.

    PubMed  CAS  Google Scholar 

  89. Weiss, K.B., P.J. Gergen, and T.A. Hodgson (1992). An economic evaluation of asthma in the United States. New England Journal of Medicine, 326, 862–866.

    PubMed  CAS  Google Scholar 

  90. Coventry, J.A., M.S. Weston, and P.M. Collins (1996). Emergency room encounters of pediatric patients with asthma: cost comparisons with other treatment settings. Journal of Ambulatory Care Management, 19, 9–21

    PubMed  CAS  Google Scholar 

  91. Segal, R., L.D. Ried, and J. Mackowiak (1995). Cost of asthma illness: Emergency department visits without admission. Pharmacy Practice Management Quarterly, 15, 72–82.

    PubMed  CAS  Google Scholar 

  92. Barnes, P.J., S. Pedersen, and W.W. Busse (1993). Efficacy and safety of inhaled corticosteroids. New developments. American Journal of Respiratory and Critical Care Medicine, 157, S1–S53.

    Google Scholar 

  93. O’Byrne, P.M. and S. Pedersen (1998). Measuring efficacy and safety of different inhaled corticosteroid preparations. Journal of Allergy and Clinical Immunology, 102, 879–886.

    PubMed  CAS  Google Scholar 

  94. Chapman, R.H., P.W. Stone, E.A. Sandberg, C. Bell, and P.J. Neumann (2000). A comprehensive league table of cost-utility ratios and a sub-table of “panel-worthy” studies. Medical Decision Making, 20, 451–467.

    PubMed  CAS  Google Scholar 

  95. Sippel, J.M., K.L. Pudula, W.M. Vollmer, A.S. Buist, and M.L. Osborne (1999). Association of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest, 115, 691–696.

    Article  PubMed  CAS  Google Scholar 

  96. Prescott, E., P. Lange, and J. Vestbo (1997). Effect of gender on hospital admission for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Health Study Group. Thorax, 52, 287–289.

    PubMed  CAS  Google Scholar 

  97. Lange, P., J. Parner, J. Bestbro, P. Schnohr, and G. Jensen (1998). A 15 year follow up study of ventilatory function in adults with asthma. New England Journal of Medicine, 339, 1194–1200.

    PubMed  CAS  Google Scholar 

  98. Ulrik, C.S. and P. Lange (1994). Decline of Lung Function in Adults with Bronchial Asthma. American Journal of Respiratory and Critical Care Medicine, 150, 629–634.

    PubMed  CAS  Google Scholar 

  99. Cook, D.G. and D.P. Strachan (1999). Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax, 54, 357–366.

    PubMed  CAS  Google Scholar 

  100. Toogood, J.H., A.E. Markov, J. Baskerville, and C. Dyson (1993). Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. Journal of Allergy and Clinical Immunology, 91, 571–579.

    PubMed  CAS  Google Scholar 

  101. Toogood, J.H. (1998). Inhaled steroid asthma treatment: ‘Primum non nocere’. Canadian Respiratory Journal, 5, 50A–53A.

    PubMed  Google Scholar 

  102. Niewoehner, C.B. and D.E. Niewoehner (1999). Steroid-induced osteoporosis. Are your asthmatic patients at risk? Postgraduate Medicine, 105, 79–83, 87–8, 91.

    PubMed  CAS  Google Scholar 

  103. Christensen-Szalanski, J.J. and G.B. Northcraft (1985). Patient compliance behavior: the effect of time on patients’ valued of treatment regiments. Social Science and Medicine, 21, 263–273.

    PubMed  CAS  Google Scholar 

  104. Greenburg, R.N. (1984). Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics, 6, 592–599.

    Google Scholar 

  105. Donahue, J.G., S.T. Weiss, J.M. Livingston, M.A. Goetsch, D.K. Greineder, and R. Platt (1997). Inhaled steroids and the risk of hospitalization for asthma. Journal of the American Medical Association, 277, 887–891.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, CT, 06520

    A. David Paltiel

  2. Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, 02108

    Karen M. Kuntz

  3. Channing Laboratory, Department of Medicine, Harvard Medical School Brigham and Women’s Hospital, Boston, MA, 02115

    Scott T. Weiss & Anne L. Fuhlbrigge

Authors
  1. A. David Paltiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen M. Kuntz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott T. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anne L. Fuhlbrigge
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Stanford University, USA

    Margaret L. Brandeau

  2. Georgia Institute of Technology, USA

    François Sainfort

  3. University of California at Los Angeles, USA

    William P. Pierskalla

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Paltiel, A.D., Kuntz, K.M., Weiss, S.T., Fuhlbrigge, A.L. (2005). An Asthma Policy Model. In: Brandeau, M.L., Sainfort, F., Pierskalla, W.P. (eds) Operations Research and Health Care. International Series in Operations Research & Management Science, vol 70. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8066-2_26

Download citation

  • DOI: https://doi.org/10.1007/1-4020-8066-2_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7629-9

  • Online ISBN: 978-1-4020-8066-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation